HURA logo

HURA
TuHURA Biosciences Inc.

15,573
Mkt Cap
$176.75M
Volume
588.00
52W High
$4.30
52W Low
$0.41
PE Ratio
-4.25
HURA Fundamentals
Price
$2.68
Prev Close
$2.78
Open
$2.78
50D MA
$1.86
Beta
0.58
Avg. Volume
773,441.18
EPS (Annual)
-$0.6272
P/B
7.70
Rev/Employee
$0.00
$33.63
Loading...
Loading...
News
all
press releases
TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 PR Newswire TAMPA, Fla., April 22, 2026 Credit...
PR Newswire·24h ago
News Placeholder
More News
News Placeholder
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of TuHURA Biosciences, Inc. (NASDAQ:HURA - Get Free Report) have received an average recommendation of "Moderate Buy" from the four analysts that are presently covering the stock, Marketbeat...
MarketBeat·8d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded TuHURA Biosciences from a "sell" rating to a "hold" rating in a research report on Wednesday...
MarketBeat·8d ago
News Placeholder
Brookline Capital Markets Comments on HURA Q1 Earnings
TuHURA Biosciences, Inc. (NASDAQ:HURA - Free Report) - Equities researchers at Brookline Capital Markets issued their Q1 2026 earnings per share estimates for TuHURA Biosciences in a research note issued on Thursday, April 9th. Brookline Capital Markets analyst K. Raja forecasts that the company wil...
MarketBeat·9d ago
News Placeholder
FY2029 EPS Forecast for TuHURA Biosciences Lifted by Analyst
TuHURA Biosciences, Inc. (NASDAQ:HURA - Free Report) - Equities research analysts at Brookline Capital Markets upped their FY2029 earnings per share (EPS) estimates for shares of TuHURA Biosciences...
MarketBeat·10d ago
News Placeholder
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations PR Newswire TAMPA, Fla., April 7, 2026 Mrs. Garofalo brings over 20 years of experience in Phase I-IV...
PR Newswire·16d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen downgraded TuHURA Biosciences from a "hold" rating to a "sell" rating in a report on Tuesday...
MarketBeat·16d ago
News Placeholder
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and...
PR Newswire·22d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Releases Earnings Results, Beats Expectations By $0.02 EPS
TuHURA Biosciences (NASDAQ:HURA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus...
MarketBeat·22d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of TuHURA Biosciences from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·24d ago
<
1
2
...
>

Latest HURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.